文献速递糖尿病

芬兰儿童糖尿病登记中诊断时无1型糖尿病相关自身抗体的儿童逾一成检出单基因变异

Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
PubMed 文献 · Diabetologia · 2022-11-23

研究评估芬兰儿童糖尿病登记(FPDR)中诊断时无1型糖尿病相关自身抗体或仅低滴度胰岛细胞抗体(ICA)的糖尿病患儿单基因糖尿病的患病率与临床表现。对152例抗体阴性和49例仅低滴度ICA阳性患儿行42基因二代测序,分别有19例(12.5%)和2例(4.1%)发现单基因变异,5例HNF1A/HNF4A/KCNJ11变异者中4例从胰岛素成功转为口服药。作者建议所有抗体阴性的儿科糖尿病患者转诊进行基因检测。

要点

  • 抗体阴性患儿中12.5%(19/152)检出单基因变异,9.2%(14/152)为致病或可能致病变异。
  • 仅低滴度ICA阳性患儿中4.1%(2/49)检出单基因变异。
  • 5例HNF1A、HNF4A或KCNJ11变异者中4例从胰岛素转为口服药成功。

核心结论

  • 抗体阴性新诊断糖尿病患儿中超过10%有与单基因糖尿病相关的遗传发现。
  • 由于遗传诊断可导致治疗重大改变,作者推荐所有抗体阴性的儿科糖尿病患者转诊进行基因检测。
  • 无其他自身抗体时仅低滴度ICA并不总是提示1型糖尿病诊断。

研究设计与样本

  • 基于芬兰儿童糖尿病登记(FPDR)的队列研究,该登记自2002年起覆盖芬兰约90%新诊断的≤15岁糖尿病患者。
  • 纳入诊断时无1型糖尿病相关自身抗体或仅低滴度ICA的患儿,使用包含42个基因的二代测序基因面板检测单基因糖尿病。
  • HNF1A变异按基因特异性标准化标准判读,仅报告致病和可能致病变异;其他基因若表型提示单基因糖尿病也报告意义未明变异。

主要发现

  • 6482例参与者中,对152例(2.3%)所有自身抗体阴性者和49例(0.8%)仅低滴度ICA阳性者进行了DNA测序。
  • 抗体阴性组19例(12.5%)发现单基因糖尿病,其中14例(9.2%)为致病或可能致病变异;仅低滴度ICA组2例(4.1%)发现单基因变异。
  • 诊断时无一例发生酮症酸中毒或携带高1型糖尿病风险的HLA基因型。
  • 受影响基因包括GCK、HNF1A、HNF4A、HNF1B、INS、KCNJ11、RFX6、LMNA和WFS1。
  • 5例HNF1A、HNF4A或KCNJ11变异患者中4例从胰岛素转为口服药成功。

临床怎么用

  • 作者推荐所有抗体阴性的儿科糖尿病患者转诊进行基因检测。
  • 无其他自身抗体时仅低滴度ICA并不总是提示1型糖尿病诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Monogenic forms of diabetes (MODY, neonatal diabetes mellitus and syndromic forms) are rare, and affected individuals may be misclassified and treated suboptimally. The prevalence of type 1 diabetes is high in Finnish children but systematic screening for monogenic diabetes has not been conducted. We assessed the prevalence and clinical manifestations of monogenic diabetes in children initially registered with type 1 diabetes in the Finnish Pediatric Diabetes Register (FPDR) but who had no type 1 diabetes-related autoantibodies (AABs) or had only low-titre islet cell autoantibodies (ICAs) at diagnosis. METHODS: The FPDR, covering approximately 90% of newly diagnosed diabetic individuals aged ≤15 years in Finland starting from 2002, includes data on diabetes-associated HLA genotypes and AAB data (ICA, and autoantibodies against insulin, GAD, islet antigen 2 and zinc transporter 8) at diagnosis. A next generation sequencing gene panel including 42 genes was used to identify monogenic diabetes. We interpreted the variants in HNF1A by using the gene-specific standardised criteria and reported pathogenic and likely pathogenic findings only. For other genes, we also reported variants of unknown significance if an individual's phenotype suggested monogenic diabetes. RESULTS: Out of 6482 participants, we sequenced DNA for 152 (2.3%) testing negative for all AABs and 49 (0.8%) positive only for low-titre ICAs (ICAlow). A monogenic form of diabetes was revealed in 19 (12.5%) of the AAB-negative patients (14 [9.2%] had pathogenic or likely pathogenic variants) and two (4.1%) of the ICAlow group. None had ketoacidosis at diagnosis or carried HLA genotypes conferring high risk for type 1 diabetes. The affected genes were GCK, HNF1A, HNF4A, HNF1B, INS, KCNJ11, RFX6, LMNA and WFS1. A switch from insulin to oral medication was successful in four of five patients with variants in HNF1A, HNF4A or KCNJ11. CONCLUSIONS/INTERPRETATION: More than 10% of AAB-negative children with newly diagnosed diabetes had a genetic finding associated with monogenic diabetes. Because the genetic diagnosis can lead to major changes in treatment, we recommend referring all AAB-negative paediatric patients with diabetes for genetic testing. Low-titre ICAs in the absence of other AABs does not always indicate a diagnosis of type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Harsunen M, Kettunen JLT, Härkönen T, et al. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register. Diabetologia. 2022. PMID: 36418577. doi:10.1007/s00125-022-05834-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。